Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Choiceone Financial
COFS
$455M
| $389K | ﹤0.01% |
16,900
+1,200
| +8% | +$27.6K |
|
3002
Immunic
IMUX
$78.4M
| $389K | ﹤0.01% |
154,900
-222,560
| -59% | -$559K |
|
|
RVLP
3003
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $389K | ﹤0.01% |
694,915
-2,500
| -0.4% | -$1.4K |
|
3004
Carrier Global
CARR
$52.5B
| $388K | ﹤0.01% |
7,805
-1,567,626
| -100% | -$77.9M |
|
3005
Vanguard Russell 1000 Value ETF
VONV
$13.6B
| $388K | ﹤0.01% |
5,600
-1,900
| -25% | -$132K |
|
3006
GEE Group
JOB
$23M
| $387K | ﹤0.01% |
755,200
-545,800
| -42% | -$280K |
|
|
AKTS
3007
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $385K | ﹤0.01% |
121,000
-54,129
| -31% | -$172K |
|
3008
Optical Cable Corp
OCC
$80.6M
| $384K | ﹤0.01% |
95,003
-1,000
| -1% | -$4.04K |
|
|
THRX
3009
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $384K | ﹤0.01% |
41,200
-89,400
| -68% | -$833K |
|
|
CFMS
3010
DELISTED
Conformis, Inc. Common Stock
CFMS
| $384K | ﹤0.01% |
175,302
+6,600
| +4% | +$14.5K |
|
3011
Capital Group Growth ETF
CGGR
$15.9B
| $383K | ﹤0.01% |
15,200
+1,300
| +9% | +$32.8K |
|
|
STRM
3012
DELISTED
Streamline Health Solutions
STRM
| $383K | ﹤0.01% |
20,125
+1,340
| +7% | +$25.5K |
|
3013
Enviri
NVRI
$983M
| $382K | ﹤0.01% |
+38,734
| New | +$382K |
|
3014
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$3.8B
| $382K | ﹤0.01% |
+13,000
| New | +$382K |
|
3015
Business First Bancshares
BFST
$723M
| $381K | ﹤0.01% |
25,300
+3,200
| +14% | +$48.2K |
|
3016
Teledyne Technologies
TDY
$26.1B
| $381K | ﹤0.01% |
+927
| New | +$381K |
|
|
WIMI
3017
WiMi Hologram Cloud
WIMI
$43.8M
| $380K | ﹤0.01% |
34,590
+860
| +3% | +$9.45K |
|
|
ALIM
3018
DELISTED
Alimera Sciences, Inc.
ALIM
| $379K | ﹤0.01% |
129,716
+28,322
| +28% | +$82.8K |
|
3019
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.57B
| $378K | ﹤0.01% |
11,000
+1,500
| +16% | +$51.5K |
|
3020
Global Indemnity Group
GBLI
$428M
| $377K | ﹤0.01% |
11,214
+3,000
| +37% | +$101K |
|
3021
Clearside Biomedical
CLSD
$25.1M
| $377K | ﹤0.01% |
336,689
-122,700
| -27% | -$137K |
|
3022
Ovid Therapeutics
OVID
$89.6M
| $376K | ﹤0.01% |
114,700
-5,900
| -5% | -$19.3K |
|
3023
LiveOne
LVO
$66.3M
| $373K | ﹤0.01% |
211,700
+85,300
| +67% | +$150K |
|
|
YI
3024
111 Inc
YI
$51.3M
| $372K | ﹤0.01% |
15,135
+4,000
| +36% | +$98.3K |
|
3025
EverCommerce
EVCM
$2.15B
| $371K | ﹤0.01% |
31,300
+16,600
| +113% | +$197K |
|